Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Karo Pharma AB buy Roth Mkm

Start price
€5.44
14.05.26 / 50%
Target price
-
14.05.27
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 14.05.27. The prediction end date can be changed by Roth_Mkm at any time.
Performance without dividends (%)
Name 1w 1m
Karo Pharma AB - -
iShares Core DAX® 0,44 % 5,90 %
iShares Nasdaq 100 1,06 % 0,92 %
iShares Nikkei 225® 1,77 % 1,23 %
iShares S&P 500 0,37 % 1,92 %

Comments by Roth_Mkm for this prediction

In the thread Karo Pharma AB diskutieren

Karooooo (KARO) had its "buy" rating reaffirmed by Roth Mkm.
Ratings data for KARO provided by MarketBeat

Stopped prediction by Roth_Mkm for Karo Pharma AB

buy
Karo Pharma AB

Start price
Target price
Perf. (%)
€5.44
17.07.26
-
17.07.27
-
24.11.22